Which endocrine complication commonly complicates TBI and how is it managed clinically?

Which endocrine complication commonly complicates TBI and how is it managed clinically?

• A. SIADH with fluid restriction
• B. Diabetes insipidus from posterior pituitary injury; treat with desmopressin and careful IV fluids; monitor electrolytes
• C. Hypoglycemia management with glucose
• D. Adrenal crisis management with hydrocortisone

Answer: (B)

After a moderate to severe brain injury, disruption of the hypothalamic‑pituitary axis commonly leads to central diabetes insipidus, caused by insufficient ADH release from the posterior pituitary. This manifests as large volumes of dilute urine, thirst, and risk of hypernatremia and hypovolemia, which can rapidly destabilize a patient if not treated. Clinically, the key is to replace the missing ADH activity and carefully manage fluids to preserve euvolemia and correct or prevent electrolyte disturbances. Desmopressin (a vasopressin analog) is used to reduce urine output and restore concentrating ability, while IV fluids are guided to maintain appropriate volume status without causing fluid overload. Regular monitoring of urine output, serum sodium, plasma osmolality, and urine osmolality guides dosing and fluid therapy. It’s worth noting that another brain-injury-related endocrine issue can be SIADH, which causes hyponatremia and is managed differently (often with fluid restriction and addressing the underlying cause). However, the scenario described most classically points to central diabetes insipidus, making desmopressin with careful fluid and electrolyte management the best approach.

After a moderate to severe brain injury, disruption of the hypothalamic‑pituitary axis commonly leads to central diabetes insipidus, caused by insufficient ADH release from the posterior pituitary. This manifests as large volumes of dilute urine, thirst, and risk of hypernatremia and hypovolemia, which can rapidly destabilize a patient if not treated. Clinically, the key is to replace the missing ADH activity and carefully manage fluids to preserve euvolemia and correct or prevent electrolyte disturbances. Desmopressin (a vasopressin analog) is used to reduce urine output and restore concentrating ability, while IV fluids are guided to maintain appropriate volume status without causing fluid overload. Regular monitoring of urine output, serum sodium, plasma osmolality, and urine osmolality guides dosing and fluid therapy.

It’s worth noting that another brain-injury-related endocrine issue can be SIADH, which causes hyponatremia and is managed differently (often with fluid restriction and addressing the underlying cause). However, the scenario described most classically points to central diabetes insipidus, making desmopressin with careful fluid and electrolyte management the best approach.